Global Irreversible Electroporation Ablators Market Growth 2025-2031

The global Irreversible Electroporation Ablators market size is predicted to grow from US$ 30.2 million in 2025 to US$ 52 million in 2031; it is expected to grow at a CAGR of 9.4% from 2025 to 2031.

Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The technique is in an experimental stage and has not been approved for use outside of clinical trials. IRE is used in the NanoKnife System.

The world"s leading manufacturers of irreversible electroporation ablators are AngioDynamics and Pulse Biosciences. North America is the largest consumption place, with a consumption market share nearly 56%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.

LP Information, Inc. (LPI) ' newest research report, the “Irreversible Electroporation Ablators Industry Forecast” looks at past sales and reviews total world Irreversible Electroporation Ablators sales in 2024, providing a comprehensive analysis by region and market sector of projected Irreversible Electroporation Ablators sales for 2025 through 2031. With Irreversible Electroporation Ablators sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Irreversible Electroporation Ablators industry.

This Insight Report provides a comprehensive analysis of the global Irreversible Electroporation Ablators landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Irreversible Electroporation Ablators portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Irreversible Electroporation Ablators market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Irreversible Electroporation Ablators and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Irreversible Electroporation Ablators.

This report presents a comprehensive overview, market shares, and growth opportunities of Irreversible Electroporation Ablators market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Generator
Part
Service

Segmentation by Application:
Liver
Pancreas
Prostate
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AngioDynamics
Pulse Biosciences

Key Questions Addressed in this Report

What is the 10-year outlook for the global Irreversible Electroporation Ablators market?

What factors are driving Irreversible Electroporation Ablators market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Irreversible Electroporation Ablators market opportunities vary by end market size?

How does Irreversible Electroporation Ablators break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.